Demographics of HIV-1 infection in Denmark: Results from the Danish HIV cohort study

被引:77
作者
Lohse, N
Hansen, ABE
Jensen-Fangel, S
Kronborg, G
Kvinesdal, B
Pedersen, C
Larsen, CS
Moller, A
Willumsen, L
Obel, N
机构
[1] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark
[2] Univ So Denmark, Odense, Denmark
[3] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[4] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark
[5] Hvidovre Univ Hosp, Dept Infect Dis, Copenhagen, Denmark
[6] Aalborg Hosp, Dept Infect Dis, Aalborg, Denmark
关键词
D O I
10.1080/00365540510031692
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We used a population-based cohort study design to describe the demographic characteristics of the HIV-infected population in Denmark and their variation over time. HIV treatment in Denmark is restricted to 9 centres, and all 3941 HIV-1 infected patients more than 15 y old seen at these centres in 1995 - 2003 were included. We found an estimated HIV prevalence of 70 per 100,000, and a mean annual incidence rate of 5.1 per 100,000 persons. The number of newly infected individuals was stable with a median of 231 per y ( period 1995 - 2002), whereas the number of deaths decreased from 166 in 1995 to 50 in 2000 (p = 0.000) and remained stable thereafter. Of the enrolled patients, 75 % were males, 80 % were Caucasian, 13 % were black African, and the primary risk behaviour was male-to-male sexual contact (44 %), heterosexual contact (36 %), and injection drug use (11 %). During the y 1995 - 2003 we found an increase in age at diagnosis (p = 0.000), and no major changes in gender, race, mode of infection, or baseline CD4+ cell count and viral load, neither overall nor within subgroups of patients. In this period 14.5 % had AIDS at the time of HIV diagnosis. Our data do not confirm concerns about unmonitored evolution in the HIV epidemic in Denmark.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 18 条
[1]  
Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4
[2]   Regional survival differences across Europe in HIV-positive people: the EuroSIDA study [J].
Chiesi, A ;
Mocroft, A ;
Dally, LG ;
Miller, V ;
Katlama, C ;
Ledergerber, B ;
Pedersen, C ;
Phillips, AN ;
Arcieri, R ;
Lundgren, JD .
AIDS, 1999, 13 (16) :2281-2288
[3]   Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: A EuroSIDA study [J].
Dragsted, UB ;
Mocroft, A ;
Vella, S ;
Viard, JP ;
Hansen, ABE ;
Panos, G ;
Mercey, D ;
Machala, L ;
Horban, A ;
Lundgren, JD .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :148-155
[4]   Research potentials and pitfalls in the use of an HIV clinical database: Chelsea and Westminster Hospital [J].
Easterbrook, PJ .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 :S28-S33
[5]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129
[6]   Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population [J].
Jensen-Fangel, S ;
Pedersen, L ;
Pedersen, C ;
Larsen, CS ;
Tauris, P ;
Moller, A ;
Sorensen, HT ;
Obel, N .
AIDS, 2004, 18 (01) :89-97
[7]   Changing demographics in an HIV-infected population: Results from an observational cohort study in western Denmark [J].
Jensen-Fangel, S ;
Pedersen, C ;
Larsen, CS ;
Tauris, P ;
Moller, A ;
Obel, N .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (10) :765-770
[8]   Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: A 5-year cohort study [J].
Lucas, GM ;
Chaisson, RE ;
Moore, RD .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (03) :321-328
[9]   Survival after diagnosis of AIDS: A prospective observational study of 2625 patients [J].
Mocroft, A ;
Youle, M ;
Morcinek, J ;
Sabin, CA ;
Gazzard, B ;
Johnson, MA ;
Phillips, AN .
BRITISH MEDICAL JOURNAL, 1997, 314 (7078) :409-413
[10]   AIDS across Europe, 1994-98: the EuroSIDA study [J].
Mocroft, A ;
Katlama, C ;
Johnson, AM ;
Pradier, C ;
Antunes, F ;
Mulcahy, F ;
Chiesi, A ;
Phillips, AN ;
Kirk, O ;
Lundgren, JD .
LANCET, 2000, 356 (9226) :291-296